References
- Howell S. J., Radford J. A., Ryder W. D., Shalet S. M. Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. J Clin Oncol 1999; 17: 1493–8
- Clark S. T., Radford J. A., Crowther D., Swindell R., Shalet S. M. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven drug hybrid regimen. J Clin Oncol 1995; 13: 134–9
- Chatterjee R., Mills W., Katz M., McGarrigle H. H., Goldstone A. H. Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma. Bone Marrow Transplant 1994; 13: 519–22
- Haines G. A., Marples B. M., Daniel P., Morris I. D. Measurment of radiation induced damage in mammalian spermatozoa using the Comet assay. Adv Exp Biol Med 1998; 444: 79–93
- Chatterjee R., Haines G. A., Perera D. M., Goldstone A., Morris I. D. Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum Reprod 2000; 15: 762–766
- Heikens J., Behrendt H., Adriaanse R., Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer 1996; 78: 2020–4
- Chatterjee R., Goldstone A. H. Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation. Bone Marrow Transplant 1996; 17: 3–11
- Glode L. M., Robinson J., Gould S. F. Protection from cyclophosphamide induced testicular damage with an analogue of gonadotrophin releasing hormone. Lancet 1981; i: 1132–1134
- Morris I. D. Protection against cytotoxic induced testis damage-experimental approaches. Eur Urol 1993; 23: 143–7
- Meistrich M. L. Hormonal stimulation of the recovery of spermatogenesis following chemo-or radiotherapy. Review article. APMIS 1998; 106: 37–45, discussion 45–6